GI & Endoscopy

Here are four updates on GI companies from the past week:

A toxicology report showed Thomas Chan was allegedly high on mushrooms when he fatally stabbed his father Andrew Chan, MD, TheRecord.com reports.

A study published in JAMA found no correlation between intense colorectal cancer surveillance and increased detection or survival rates, Clinical Oncology News reports.

The California Insurance Commission is suing AbbVie saying the drugmaker allegedly offered physicians kickbacks for its popular, gastroenterology drug Humira, which resulted in $1.2 billion in fraudulent claims, the San Francisco Chronicle reports.

Prescient Medicine Holdings and Metabiomics partnered to develop a microbiome diagnostic platform to diagnose gastrointestinal diseases including Crohn's disease, ulcerative colitis and irritable bowel syndrome.

Jacob R. Karr, MD, is a gastroenterologist at Lafayette, La.-based The Gastro Clinic.

Yonatan Hillman, MD, joined Duluth, Minn.-based St. Luke's Gastroenterology Associates.

The FDA awarded Motus GI's Pure-Vu Slim Sleeve 510(k) clearance, expanding Motus' reach to encompass the full range of gastrointestinal procedures.

A Kanawha County ( W.Va.) circuit court judge dropped a sexual assault and a sexual abuse count against Charleston, W.Va., gastroenterologist Steven Matulis, MD, the Charleston Gazette-Mail reports.

Akira Horiuchi, MD, was awarded the Ig Nobel Prize for medical education for his colonoscopy research, The Japan Times reports.